s

shangpharm

10000 employees

ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides

Investor insights

Sectors invested in

Biotechnology6
Therapeutics5
Health Care5
Medical3
drug discovery and immunology2
Clinical Trials2
Pharmaceutical1
Neuroscience1
Tauopathies1
Neurodegenerative Diseases1
Alzheimer's Disease1
Health Diagnostics1

Funding rounds participated in

$47M sweet spot round size

Most of their 6 investments are in rounds between $11M and $52M

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care

Date founded

2002

Investments made

C

Circle Pharma, Inc. raised $45M on March 17, 2020

Investors: Nextech Invest, Berkeley Catalyst Fund, Lifeforce Capital, The Column Group and shangpharm

M

Morphic Therapeutic raised $80M on September 25, 2018

Investors: Omega Funds, Novo Holdings, S.R. One Ltd, The Invus Group, Polaris Partners and shangpharm

A

APRINOIA Therapeutics raised $11M on January 16, 2018

Investors: TaiAn Technologies Corporation and shangpharm

O

Obsidian Therapeutics raised $50M on December 6, 2017

Investors: GV, Takeda UK Limited, Atlas Venture, Vertex Ventures HC and shangpharm

C

Circle Pharma, Inc. raised $4.5M on December 21, 2016

Investors: Mission Bay Capital, Lifeforce Capital and shangpharm

M

Morphic Therapeutic raised $52M on June 30, 2016

Investors: Omega Funds, S.R. One Ltd, Polaris Partners and shangpharm

FAQ